PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
30701693-7	2019	Our results showed that the expression of miR-345 and miR-498 significantly decreased in gefitinib resistant NSCLC cells.	Gefitinib	89-98	microRNA 345	Homo sapiens	42-49
30701693-0	2019	Trans-3,5,4 -trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.	trans-3,5,4 -trimethoxystilbene	0-31	microRNA 345	Homo sapiens	129-136
30701693-8	2019	TMS pre-treatment significantly upregulated the expression of miR-345 and miR-498 increasing the sensitivity of NSCLC cells to gefitinib and inducing apoptosis.	Gefitinib	127-136	microRNA 345	Homo sapiens	62-69
30701693-10	2019	The combination of TMS and gefitinib promoted apoptosis also by miR-345 and miR-498 targeting the MAPK/c-Fos and AKT/Bcl-2 signalling pathways.	Gefitinib	27-36	microRNA 345	Homo sapiens	64-71
30576747-2	2019	This temperature and pH-responsive pentablock copolymer system was able to restore miR-345, making xenograft tumors more susceptible to GEM, the standard therapy for PC.	pentablock copolymer	35-55	microRNA 345	Homo sapiens	83-90
30655879-6	2019	The expression levels of miR-101 and miR-345 in BEL-7404 pSUPER.neo-miR-101 group and BEL-7404 pSUPER.neo-miR-345 group were significantly higher than those in BEL-7404 pSUPER.neo group (P<0.05).	mir-101	25-32	microRNA 345	Homo sapiens	106-113
30655879-6	2019	The expression levels of miR-101 and miR-345 in BEL-7404 pSUPER.neo-miR-101 group and BEL-7404 pSUPER.neo-miR-345 group were significantly higher than those in BEL-7404 pSUPER.neo group (P<0.05).	neo	64-67	microRNA 345	Homo sapiens	37-44
30655879-8	2019	The expression of HBV DNA in MHCC97-L pSUPER.neo-miR-101 group was significantly lower than that in MHCC97-L pSUPER.neo group (P<0.05), and the expression of HBV DNA in MHCC97-L pSUPER.neo-miR-345 group was significantly higher than that in MHCC97-L pSUPER.neo group (P<0.05).	neo	45-48	microRNA 345	Homo sapiens	192-199
30655879-9	2019	The expression of HbsAg in MHCC97-L pSUPER.neo-miR-101 group was significantly lower than that in MHCC97-L pSUPER.neo group (P<0.05), and the expression of HbsAg in MHCC97-L pSUPER.neo-miR-345 group was significantly higher than that in MHCC97-L pSUPER.neo group (P<0.05).	neo-mir-101	43-54	microRNA 345	Homo sapiens	188-195
30655879-9	2019	The expression of HbsAg in MHCC97-L pSUPER.neo-miR-101 group was significantly lower than that in MHCC97-L pSUPER.neo group (P<0.05), and the expression of HbsAg in MHCC97-L pSUPER.neo-miR-345 group was significantly higher than that in MHCC97-L pSUPER.neo group (P<0.05).	neo	43-46	microRNA 345	Homo sapiens	188-195
30655879-12	2019	The proliferation of BEL-7404 cells in the BEL-7404 pSUPER.neo-miR-345 group was significantly higher than that in the BEL-7404 pSUPER.neo group (P<0.05).	bel-7404	21-29	microRNA 345	Homo sapiens	63-70
30655879-12	2019	The proliferation of BEL-7404 cells in the BEL-7404 pSUPER.neo-miR-345 group was significantly higher than that in the BEL-7404 pSUPER.neo group (P<0.05).	bel-7404	43-51	microRNA 345	Homo sapiens	63-70
30655879-12	2019	The proliferation of BEL-7404 cells in the BEL-7404 pSUPER.neo-miR-345 group was significantly higher than that in the BEL-7404 pSUPER.neo group (P<0.05).	neo	59-62	microRNA 345	Homo sapiens	63-70
26247574-2	2015	METHODS: miR-345 was overexpressed in PC cells by stable transfection, and its effect on growth, apoptosis and mitochondrial-membrane potential was examined by WST-1, Hoechst-33342/Annexin-V, and JC-1 staining, respectively.	bisbenzimide ethoxide trihydrochloride	167-180	microRNA 345	Homo sapiens	9-16
23577194-0	2013	Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells.	Curcumin	74-82	microRNA 345	Homo sapiens	109-121
23577194-15	2013	Moreover, the core protein inhibited curcumin-induced apoptosis through p21(Waf1/Cip1)-targeting microRNA-345 in Huh7 cells.	Curcumin	37-45	microRNA 345	Homo sapiens	97-109
21665895-8	2011	The expression of mir-345 was significantly increased after 5-aza-dC treatment.	Decitabine	60-68	microRNA 345	Homo sapiens	18-25
24940606-0	2014	miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan.	Irinotecan	151-161	microRNA 345	Homo sapiens	0-7
24940606-9	2014	In addition, high miR-345 expression was associated with lack of response to treatment with cetuximab and irinotecan.	Irinotecan	106-116	microRNA 345	Homo sapiens	18-25